(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Pregnancy
This study will evaluate use of sumatriptan or naratriptan among pregnant women. Candidates must document the use of either drug during pregnancy.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat187.html 
.
-----
Epilepsy
If you have been diagnosed with epilepsy with simple partial seizures or complex partial seizures, have had 2-to-40 seizures over a 28-day period, and are on a stable dose of one or two marketed antiepileptic drugs, you may qualify for this study.
The research site is in Grand Rapids, Mich.
More information
Please see http://www.centerwatch.com/patient/studies/cat62.html .
-----
Seizure Disorders
If you have either completed the double-blind trial, SP902, or met the exit criteria for that trial, you may be eligible to participate in this additional study.
The research site is in Pikesville, Md.
More information
Please see http://www.centerwatch.com/patient/studies/cat138.html .
-----
Copyright 2008 Thomson CenterWatch . All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved. 
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.